Loading, please wait...
|
St. Louis College of Pharmacy is proud to host the...
9th Annual Resident Research Conference
Wednesday, May 23, 2018
1:00 - 4:30 PM
ARB 3rd Floor Classrooms
Please join us for the 9th Annual Resident Research Conference. PGY1 and PGY2 pharmacy residents from St. Louis College of Pharmacy and the St. Louis area will showcase their research over the past year through this mini-series. Three finalists will be selected in acknolwedgement of their superior work. All are welcome and encouraged to attend.
Additional information can be found below.
PARKING:
Parking will be provided to registered participants at no additional charge in the garage located at 4531 Children's Place, St. Louis, MO 63110. Additional details, including driving directions and a downloadable map, can be found here.
NOTE: Parking can only be reserved for those who register and indicate a need in their registration.
HANDOUT:
For the complete abstracts, please download our event flyer or click here.
SCHEDULE:
|
|
SESSION 1
|
||||
|
|
ARB Room 304
|
ARB Room 305
|
ARB Room 354
|
ARB Room 355
|
|
1:10 – 1:30 pm
|
*Megan Chittum, Pharm.D Dexmedetomidine dose requirements to achieve goal Richmond Agitation-Sedation Scale (RASS) score in obese compared to non-obese intensive care unit (ICU) patients
|
Nicole Gramlich, Pharm.D.
Glycemic Control in an Inpatient Diabetic Population: A Comparison of Weight-Based Insulin Dosing vs. Home Regimen vs. Physician Preference
|
Nalinoë Kernizan, Pharm.D.
Evaluation of Prescribing Patterns for the Treatment of Bipolar Disorder in Pregnancy
|
Amanda Bultas, Pharm.D.
Predictors of Treatment Failure Following De-escalation to a Fluoroquinolone in Culture Negative Nosocomial Pneumonia
|
|
1:30 – 1:50 pm
|
*Haley N. Ilcewicz, Pharm.D.
Evaluation of the Impact of an Inpatient Hyperglycemia Protocol on Glycemic Control
|
Sara E. Lingow, Pharm.D.
Clinical Inertia Amongst Healthcare Providers in the Management of Patients with Type 2 Diabetes
|
Katie Neighbors, Pharm.D.
Metformin’s effect on A1c in prediabetics taking atypical antipsychotics
|
Katy Kehl, Pharm.D.
Discontinuation of Mediations in HIV Wasting Syndrome
|
|
1:50 – 2:10 pm
|
*Kaitlen Shumate, Pharm.D.
Evaluating Potential Predictors of Bleeding Events in Patients Taking Direct Oral Anticoagulants
|
Danielle Bozzardi, Pharm.D.
Assessment of Risk Factors for Non-Therapeutic Anti-Factor Xa Levels in Patients on Treatment Dose Enoxaparin
|
Katie Peppin, Pharm.D.
Evaluating the safety and tolerability of inpatient sacubitril/valsartan initiation in a community hospital
|
Xing Tan, Pharm.D.
Efficacy and safety of trimethoprim/sulfamethoxazole versus linezolid for skin and skin structure infections
|
|
2:10 – 2:30 pm
|
*Jennifer Voong, Pharm.D
Evaluation of Vasopressor Discontinuation
|
Paige Hagen, Pharm.D.
A Retrospective Review Comparing Team-Based Care to Usual Care for HbA1C Lowering Over 12 Months
|
Mara Lacy Hofherr, Pharm.D.
Midodrine use for vasopressor weaning in intensive care patients
|
Melissa Gaul, Pharm.D.
Evaluation of Antibiotic Dosing Adjustments and Effect on Clinical Outcomes in Critically Ill Patients with Sepsis at an Academic Medical Center
|
|
SESSION 2
|
||||
|
2:40 – 3:00 pm
|
Michael Serlin, Pharm.D.
Impact of Pharmacist Interventions on COPD-Related Quality of Life
|
Meredith Voss, Pharm.D.
Effectiveness of a Pharmacist-driven Monitoring Program for Patients Using Continuous Glucose Monitors
|
Fadumo Mire, Pharm.D
Implementation of audiology screenings in pediatric cystic fibrosis patients at risk of aminoglycoside or vancomycin-induced ototoxicity
|
Mikayla A. Muzzey, Pharm.D.
Evaluation of the effectiveness of flecainide at maintaining symptomatic control in patients with atrial fibrillation
|
|
3:00 – 3:20pm
|
Bianca Daisy, Pharm.D.
IPPE or APPE? Community Pharmacy Preceptor Perceptions of Where to Incorporate Specific Rotation Activities
|
Yasmine Zeid, Pharm.D.
Evaluation of choice of second therapy phase anti-epileptic drug and resolution of status epilepticus
|
Hannah Terry, Pharm.D.
Comparison of Effect of Long-Acting Naltrexone vs. Oral Naltrexone Use on Alcohol Detoxification Readmission Rates
|
Taylor Hebenstreit, Pharm.D.
Comparison of Aspirin vs. Warfarin for Venous Thromboembolism (VTE) Prophylaxis after Orthopedic Surgery
|
|
3:20 – 3:40 pm
|
Della Mitchell, Pharm.D
Pharmacy Practice in Ambulatory Care
|
Lindsay M. Schroeder, Pharm.D.
Hospital-onset seizures: epidemiology, management, and outcomes
|
Jeffrey Pasucal, Pharm.D.
Pharmacist Involvement in Oncology Based Patient Reported Side Effects in Community-Based Specialty Pharmacies
|
Nicole Phillips, Pharm.D.
Evaluation of Enoxaparin Dosing for Pediatric Venous Thromboembolism: A Retrospective Review
|
|
3:40 – 4:00 pm
|
Kacie Kuehn, Pharm.D.
Characterizing Pharmacy Resident Perceptions of a Chief Resident Position
|
Shelby E. Meyers, Pharm.D.
Evaluation of full-dose anticoagulation in chronic liver disease
|
Kaci Kehrt, Pharm.D.
Characterizing Prescribing Practices of Opioids in the Emergency Department at the VA St. Louis Health Care System John Cochran Division
|
Melissa J. Nicholson, Pharm.D.
Safety and efficacy of adjusted-dose venous thromboembolism prophylaxis in morbidly obese patients
|
|
*Finalist for Resident Research Award
|
||||
|
|
|
Continuing Pharmacy Education (CPE):
CE credit is not offered as part of this activity.
HANDOUT:
For the complete abstracts, please download our event flyer or click here.
|
Date: May 23, 2018 01:00 PM - 04:00 PM
Fee
$0.00
Activity Type
- Knowledge
Joint Provider(s)
9th Annual Resident Research Symposium
|
SESSION 1
|
||||
|
|
ARB Room 304
|
ARB Room 305
|
ARB Room 354
|
ARB Room 355
|
|
1:10 – 1:30 pm
|
*Megan Chittum, Pharm.D Dexmedetomidine dose requirements to achieve goal Richmond Agitation-Sedation Scale (RASS) score in obese compared to non-obese intensive care unit (ICU) patients
|
Nicole Gramlich, Pharm.D.
Glycemic Control in an Inpatient Diabetic Population: A Comparison of Weight-Based Insulin Dosing vs. Home Regimen vs. Physician Preference
|
Nalinoë Kernizan, Pharm.D.
Evaluation of Prescribing Patterns for the Treatment of Bipolar Disorder in Pregnancy
|
Amanda Bultas, Pharm.D.
Predictors of Treatment Failure Following De-escalation to a Fluoroquinolone in Culture Negative Nosocomial Pneumonia
|
|
1:30 – 1:50 pm
|
*Haley N. Ilcewicz, Pharm.D.
Evaluation of the Impact of an Inpatient Hyperglycemia Protocol on Glycemic Control
|
Sara E. Lingow, Pharm.D.
Clinical Inertia Amongst Healthcare Providers in the Management of Patients with Type 2 Diabetes
|
Katie Neighbors, Pharm.D.
Metformin’s effect on A1c in prediabetics taking atypical antipsychotics
|
Katy Kehl, Pharm.D.
Discontinuation of Mediations in HIV Wasting Syndrome
|
|
1:50 – 2:10 pm
|
*Kaitlen Shumate, Pharm.D.
Evaluating Potential Predictors of Bleeding Events in Patients Taking Direct Oral Anticoagulants
|
Danielle Bozzardi, Pharm.D.
Assessment of Risk Factors for Non-Therapeutic Anti-Factor Xa Levels in Patients on Treatment Dose Enoxaparin
|
Katie Peppin, Pharm.D.
Evaluating the safety and tolerability of inpatient sacubitril/valsartan initiation in a community hospital
|
Xing Tan, Pharm.D.
Efficacy and safety of trimethoprim/sulfamethoxazole versus linezolid for skin and skin structure infections
|
|
2:10 – 2:30 pm
|
*Jennifer Voong, Pharm.D
Evaluation of Vasopressor Discontinuation
|
Paige Hagen, Pharm.D.
A Retrospective Review Comparing Team-Based Care to Usual Care for HbA1C Lowering Over 12 Months
|
Mara Lacy Hofherr, Pharm.D.
Midodrine use for vasopressor weaning in intensive care patients
|
Melissa Gaul, Pharm.D.
Evaluation of Antibiotic Dosing Adjustments and Effect on Clinical Outcomes in Critically Ill Patients with Sepsis at an Academic Medical Center
|
|
Break
|
||||
|
SESSION 2
|
||||
|
2:40 – 3:00 pm
|
Michael Serlin, Pharm.D.
Impact of Pharmacist Interventions on COPD-Related Quality of Life
|
Meredith Voss, Pharm.D.
Effectiveness of a Pharmacist-driven Monitoring Program for Patients Using Continuous Glucose Monitors
|
Fadumo Mire, Pharm.D
Implementation of audiology screenings in pediatric cystic fibrosis patients at risk of aminoglycoside or vancomycin-induced ototoxicity
|
Mikayla A. Muzzey, Pharm.D.
Evaluation of the effectiveness of flecainide at maintaining symptomatic control in patients with atrial fibrillation
|
|
3:00 – 3:20pm
|
Bianca Daisy, Pharm.D.
IPPE or APPE? Community Pharmacy Preceptor Perceptions of Where to Incorporate Specific Rotation Activities
|
Yasmine Zeid, Pharm.D.
Evaluation of choice of second therapy phase anti-epileptic drug and resolution of status epilepticus
|
Hannah Terry, Pharm.D.
Comparison of Effect of Long-Acting Naltrexone vs. Oral Naltrexone Use on Alcohol Detoxification Readmission Rates
|
Taylor Hebenstreit, Pharm.D.
Comparison of Aspirin vs. Warfarin for Venous Thromboembolism (VTE) Prophylaxis after Orthopedic Surgery
|
|
3:20 – 3:40 pm
|
Della Mitchell, Pharm.D
Pharmacy Practice in Ambulatory Care
|
Lindsay M. Schroeder, Pharm.D.
Hospital-onset seizures: epidemiology, management, and outcomes
|
Jeffrey Pasucal, Pharm.D.
Pharmacist Involvement in Oncology Based Patient Reported Side Effects in Community-Based Specialty Pharmacies
|
Nicole Phillips, Pharm.D.
Evaluation of Enoxaparin Dosing for Pediatric Venous Thromboembolism: A Retrospective Review
|
|
3:40 – 4:00 pm
|
Kacie Kuehn, Pharm.D.
Characterizing Pharmacy Resident Perceptions of a Chief Resident Position
|
Shelby E. Meyers, Pharm.D.
Evaluation of full-dose anticoagulation in chronic liver disease
|
Kaci Kehrt, Pharm.D.
Characterizing Prescribing Practices of Opioids in the Emergency Department at the VA St. Louis Health Care System John Cochran Division
|
Melissa J. Nicholson, Pharm.D.
Safety and efficacy of adjusted-dose venous thromboembolism prophylaxis in morbidly obese patients
|
|
*Finalist for Resident Research Award
|
||||
Date:
05/23/18
Time:
01:00 PM - 04:30 PM
